Search Results - Kate L Mahon

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: L... by Lisa M Butler, Anthony M Joshua, Tahlia Scheinberg, James Kench, Martin Stockler, Kate L Mahon, Lucille Sebastian, Phillip Stricker, H Woo, Ruban Thanigasalam, Nariman Ahmadi, Margaret M Centenera, Lisa G Horvath

    Published in BMJ Open (2020-01-01)
    Get full text
    Article


  2. 2

    Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer by Manish Kohli, Winston Tan, Tiantian Zheng, Amy Wang, Carlos Montesinos, Calven Wong, Pan Du, Shidong Jia, Siddhartha Yadav, Lisa G. Horvath, Kate L. Mahon, Edmond M. Kwan, Heidi Fettke, Jianjun Yu, Arun A. Azad

    Published in EBioMedicine (2020-04-01)
    Get full text
    Article


Search Tools: